Neuraxis, Inc. (NRXS)
NYSE: NRXS · Electromedical & Electrotherapeutic Apparatus · Carmel, IN · filing with the SEC since 2022
Who runs Neuraxis, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Carrico Brian Allen
Chief Executive Officer. First filing Aug 2023, latest Oct 8, 2026, 2 filings in all.
Officers reporting now
5
of 9 people with a filing in the last fifteen months
Directors reporting now
4
13 people on the record since 2023
Officerssales are open-market, Oct 8, 2025 to Oct 8, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Carrico Brian Allen | Chief Executive Officer | Aug 2023 | Oct 8, 2026 | none |
| Henrichs Timothy Robert | Chief Financial Officer | Aug 2023 | Oct 8, 2026 | none |
| Carrico Thomas Joeseph | CRO, CCO, CPO | Aug 2023 | Oct 8, 2026 | none |
| Blanchard Craig Thomas | Chief Commercial Officer | Sep 2026 | Sep 29, 2026 | none |
| Miranda Adrian | CMO, SVP Science & Tech | Sep 2023 | Aug 26, 2026 | none |
Directorssales are open-market, Oct 8, 2025 to Oct 8, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Aharon Gil | director | Nov 2024 | Aug 17, 2026 | none |
| Ferge Kristin A | director | Mar 2024 | Aug 17, 2026 | none |
| Keyser Jane Elizabeth | director | Aug 2023 | Aug 17, 2026 | none |
| Watkins Bradley Mitchell | director | Aug 2023 | Aug 17, 2026 | none |
Owners of more than 10% of a classsales are open-market, Oct 8, 2025 to Oct 8, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Hannasch Brian | 10% owner | Dec 2023 | Feb 13, 2026 | none |
Earlier names on the record5, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.